Teriparatide [human parathyroid hormone (PTH)(1–34)] is a new therapeutic option for osteoporosis that has been shown to induce new bone formation onto trabecular and cortical surfaces in monkeys, women, and men [14, 15]. Here, PTH is linked to osteoporosis.